SCHEMBL20899779

SCHEMBL20899779

CCOC(=O)N(CC)CCc1csc(NS(=O)(=O)c2cccc(Cl)c2C)n1

nearest known ligand 0.74

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 6/20 0.74
▸ HSD17B1 P14061 2/20 0.74
▸ HSD17B2 P37059 2/20 0.74
▸ KMT2A Q03164 6/20 0.50
▸ MEN1 O00255 5/20 0.50
▸ POLB P06746 2/20 0.50
▸ ALDH1A1 P00352 3/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HTT P42858 1/20 0.44
▸ PKM P14618 2/20 0.42
▸ LMNA P02545 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3618080 0.90 HSD11B1 (0.72) HSD11B1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL3617334 0.90 HSD11B1 (0.75) HSD11B1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL677390 0.85 HSD11B1 (1.00) HSD11B1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL27534009 0.85 HSD11B1 (0.69) HSD11B1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL3623421 0.84 HSD11B1 (0.68) HSD11B1HSD17B1HSD17B2KMT2AMEN1
Hydrochloric Acid SCHEMBL3616536 0.84 HSD11B1 (0.68) HSD11B1HSD17B1HSD17B2KMT2AMEN1
Hydrochloric Acid SCHEMBL3618123 0.82 HSD11B1 (0.64) HSD11B1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL3614035 0.82 HSD11B1 (0.77) HSD11B1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL3612961 0.81 HSD11B1 (0.65) HSD11B1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL3619776 0.81 HSD11B1 (0.85) HSD11B1HSD17B1HSD17B2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019075394-A1 COMPOUNDS FOR TREATMENT OF EMOTIONAL/PSYCHOLOGICAL SYMPTOMS IN FRAGILE X SYNDROME VANDERKLISH PETER (US) 2019-04-18 — — WO disclosed
Send feedback